GlassScriptPhysician profile
Barbara Ann Michna
NPI 1710939830
$2,622.32
in general payments reported to CMS, 2019-2025
42 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $134 · 2021: $218 · 2022: $147 · 2023: $299 · 2024: $1,162 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,930.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $389.79 | 2024-2025 | Tisseel, Perclot |
| Molli Surgical (US) INC | $358.67 | 2023-2024 | |
| Stryker Corporation | $326.75 | 2024-2025 | Molli |
| Abbvie INC. | $159.80 | 2021-2025 | |
| Smith+Nephew, INC. | $112.82 | 2019-2025 | Stravix |
| Merck Sharp & Dohme LLC | $91.02 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Intuitive Surgical, INC. | $90.34 | 2019-2020 | |
| Ethicon US, LLC | $88.73 | 2020-2023 | Harmonic, Echelon Flex |
| Astrazeneca Pharmaceuticals LP | $75.69 | 2021-2024 | Tagrisso |
| Medtronic, INC. | $73.94 | 2024 | Progrip |
| Davol INC. | $70.22 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $67.91 | 2021-2022 | |
| Janssen Biotech, INC. | $56.40 | 2023-2024 | Carvykti, Imbruvica, Tecvayli |
| Royal Biologics, INC. | $49.49 | 2024 | |
| Puma Biotechnology, INC. | $49.30 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Michna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.